58 Chapter 3 36. Goh C, Knight JC. Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches. The Lancet Respiratory medicine. 2017;5(3):212-23. 37. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clinical microbiology reviews. 2012;25(4):609-34. 38. Holcomb ZE, Tsalik EL, Woods CW, McClain MT. Host-Based Peripheral Blood Gene Expression Analysis for Diagnosis of Infectious Diseases. Journal of clinical microbiology. 2017;55(2):360-8. 39. PR newswire. News releases: Revolutionary Diagnostic SeptiCyte™ LAB Cleared By FDA for Suspected Sepsis Patients 2017 [Available from: http://www.prnewswire.com/newsreleases/revolutionary-diagnostic-septicyte-lab-cleared-by-fda-for-suspected-sepsispatients-300411470.html. Accessed April 19, 2017. 40. McHugh L, Seldon TA, Brandon RA, Kirk JT, Rapisarda A, Sutherland AJ, et al. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. PLoS medicine. 2015;12(12):e1001916. 41. Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Science translational medicine. 2015;7(287):287ra71. 42. Bauer M, Giamarellos-Bourboulis EJ, Kortgen A, Moller E, Felsmann K, Cavaillon JM, et al. A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis - A Prospective Multicenter Phase II Diagnostic Study. EBioMedicine. 2016;6:114-25. 43. Scicluna BP, Klein Klouwenberg PM, van Vught LA, Wiewel MA, Ong DS, Zwinderman AH, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. American journal of respiratory and critical care medicine. 2015;192(7):82635. 44. Sweeney TE, Khatri P. Comprehensive Validation of the FAIM3:PLAC8 Ratio in Timematched Public Gene Expression Data. American journal of respiratory and critical care medicine. 2015;192(10):1260-1. 45. Sweeney TE, Khatri P. Benchmarking Sepsis Gene Expression Diagnostics Using Public Data. Critical care medicine. 2017;45(1):1-10. 46. Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Science translational medicine. 2016;8(322):322ra11. 47. Suarez NM, Bunsow E, Falsey AR, Walsh EE, Mejias A, Ramilo O. Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults. The Journal of infectious diseases. 2015;212(2):213-22. 48. Parnell GP, McLean AS, Booth DR, Armstrong NJ, Nalos M, Huang SJ, et al. A distinct influenza infection signature in the blood transcriptome of patients with severe communityacquired pneumonia. Critical care (London, England). 2012;16(4):R157. 49. Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Science translational medicine. 2016;8(346):346ra91. 50. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. 2007;109(5):2066-77. 51. Hu X, Yu J, Crosby SD, Storch GA. Gene expression profiles in febrile children with defined viral and bacterial infection. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(31):12792-7.
RkJQdWJsaXNoZXIy MTk4NDMw